WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis

被引:211
作者
Guo, JK
Menke, AL
Gubler, MC
Clarke, AR
Harrison, D
Hammes, A
Hastie, ND
Schedl, A
机构
[1] Max Delbruck Ctr Mol Med, Berlin, Germany
[2] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland
[3] Hop Necker Enfants Malad, INSERM, Dept Pediat Nephrol, Paris, France
[4] Cardiff Sch Biosci, Cardiff, S Glam, Wales
[5] Univ Edinburgh, Sch Med, Dept Pathol, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1093/hmg/11.6.651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glomerular disease is one of the most common causes of end-stage renal failure. Increasing evidence suggests that these glomerulopathies are frequently caused by primary lesions in the renal podocytes. One of the major consequences of podocyte lesions is the accumulation of mesangial matrix in the glomerular basement membrane, a process called glomerulosclerosis. Mesangial sclerosis is one of the most consistent findings in Denys-Drash patients and can be caused by dominant mutations in the Wilms' tumor 1 gene (WT1). The underlying mechanism, however, is poorly understood. WT1 is expressed in the podocytes throughout life, but its function in this cell type is unknown. Combining Wt1-knockout and inducible yeast artificial chromosome transgenic mouse models, we demonstrate that reduced expression levels of WT1 result in either crescentic glomerulonephritis or mesangial sclerosis depending on the gene dosage. Strikingly, the two podocyte-specific genes nphs1 and podocalyxin are dramatically downregulated in mice with decreased levels of Wt1, suggesting that these two genes act downstream of Wt1. Taken together, our data provide genetic evidence that reduced levels of Wt1 are responsible for the pathogenesis of two distinct renal diseases and offer a molecular explanation for the increased occurrence of glomerulosclerosis in patients with WAGR syndrome.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 45 条
[1]   THE EXPRESSION OF THE WILMS-TUMOR GENE, WT1, IN THE DEVELOPING MAMMALIAN EMBRYO [J].
ARMSTRONG, JF ;
PRITCHARDJONES, K ;
BICKMORE, WA ;
HASTIE, ND ;
BARD, JBL .
MECHANISMS OF DEVELOPMENT, 1993, 40 (1-2) :85-97
[2]   WT1 MUTATIONS ASSOCIATED WITH INCOMPLETE DENYS-DRASH SYNDROME DEFINE A DOMAIN PREDICTED TO BEHAVE IN A DOMINANT-NEGATIVE FASHION [J].
BARDEESY, N ;
ZABEL, B ;
SCHMITT, K ;
PELLETIER, J .
GENOMICS, 1994, 21 (03) :663-665
[3]  
BROWN KW, 1992, ONCOGENE, V7, P763
[4]   A non-AUG translational initiation event generates novel WT1 isoforms [J].
Bruening, W ;
Pelletier, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8646-8654
[5]   ISOLATION, CHARACTERIZATION, AND EXPRESSION OF THE MURINE WILMS-TUMOR GENE (WT1) DURING KIDNEY DEVELOPMENT [J].
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
GLASER, T ;
HOUSMAN, DE .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) :1707-1712
[6]  
DiTullio MT, 1996, MED PEDIATR ONCOL, V26, P325, DOI 10.1002/(SICI)1096-911X(199605)26:5<325::AID-MPO4>3.0.CO
[7]  
2-K
[8]   Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin [J].
Doyonnas, R ;
Kershaw, DB ;
Duhme, C ;
Merkens, H ;
Chelliah, S ;
Graf, T ;
McNagny, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (01) :13-27
[9]   HOMOZYGOUS DELETION IN WILMS-TUMORS OF A ZINC-FINGER GENE IDENTIFIED BY CHROMOSOME JUMPING [J].
GESSLER, M ;
POUSTKA, A ;
CAVENEE, W ;
NEVE, RL ;
ORKIN, SH ;
BRUNS, GAP .
NATURE, 1990, 343 (6260) :774-778
[10]   HOMOZYGOUS INACTIVATION OF WTI IN A WILMS-TUMOR ASSOCIATED WITH THE WAGR SYNDROME [J].
GESSLER, M ;
KONIG, A ;
MOORE, J ;
QUALMAN, S ;
ARDEN, K ;
CAVENEE, W ;
BRUNS, G .
GENES CHROMOSOMES & CANCER, 1993, 7 (03) :131-136